Global Diabetes Rate Has Doubled In Last 30 Years: Study
The percentage of adults suffering from diabetes across the world has doubled over the past three decades, the biggest rises ...
Bloomberg L.P.11h
Cancer Patients in England Denied Access to Drugs Over Price Standoff
Jon Missin considers himself lucky. The 51-year-old from Northamptonshire, in central England, was diagnosed with incurable ...
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Health Insurance Premiums Are Rising in 35 States—Is Yours One of Them?
Six states will see price cuts for ACA (Obamacare) plans, but all the others will see at least some increases. Find out where ...
Acsh.org1d
The Sticky and Sickly(?) Price of America’s Sugar Subsidy
Sugar is America’s favorite carb and the sweetheart of federal subsidies. Uncle Sam has been feeding the sugar industry for over two centuries while we foot the bill, shelling out for a market ...
San Francisco Examiner2d
California Residents Are Using GLP-1s at the 11th Lowest Rate in the Country
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Messenger-Inquirer2d
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Cfr.org5d
RealEcon Welcomes Assistant Administrator Michael Schiffer to discuss USAID Priorities in the Indo-Pacific
Development Indo-Pacific RealEcon Bilateral development assistance has long been an important tool of American leadership.